PET translates neurophysiology into images: A review to stimulate a network between neuroimaging and basic research

In the last decades there has been a progressive advance in the development of techniques able to explore in humans neurophysiologic and neurochemical processes. Positron emission tomography (PET) is a very powerful technique allowing to study a quite variable range of physiological and biochemical processes in the healthy subjects and in diseases. Apart from its capacity to provide pathophysiological information, PET is also important for the objective assessment of therapeutic efficacy. Initial studies were performed measuring cerebral metabolic rate for glucose (CMRglc) and cerebral blood flow (CBF), representing an indirect index of synaptic activity. The advent of receptor tracers allowed measuring other important physiological parameters, such as receptor occupancy, and endogenous release. In neuropsychiatric disorders, as Alzheimer disease, schizophrenia, epilepsy and Huntington disease, PET has been useful to elaborate hypothesis of the pathogenesis, to relate symptoms to biological variables and to study individuals at increased risk. The new concepts of neurovascular unit and default network, preferentially active at rest, can significantly change the approach of PET, with images reflecting a complex scenario, not merely limited to neural activity, but involving the activity of the entire neurovascular unit and the multifunctional role of astrocytes. To detect dysfunction of the dialog between glutamatergic neurons and astrocytes could lead to a better understanding of altered functional brain images. In this direction a professional network between PET researchers and basic scientists, could give a determinant improvement in the capability to understand the complex physiological and pathophysiological cerebral world. J. Cell. Physiol. 226: 948–961, 2011. © 2010 Wiley‐Liss, Inc.

[1]  A. Connelly,et al.  Longitudinal Quantitative Hippocampal Magnetic Resonance Imaging Study of Adults with Newly Diagnosed Partial Seizures: One‐Year Follow‐Up Results , 1998, Epilepsia.

[2]  W. Webb,et al.  Neural Activity Triggers Neuronal Oxidative Metabolism Followed by Astrocytic Glycolysis , 2004, Science.

[3]  S. DeKosky,et al.  Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  E. Courchesne,et al.  Attentional Activation of the Cerebellum Independent of Motor Involvement , 1997, Science.

[5]  B H Brinkmann,et al.  Subtraction SPECT co-registered to MRI improves postictal SPECT localization of seizure foci , 1999, Neurology.

[6]  A. Young,et al.  A polymorphic DNA marker genetically linked to Huntington's disease , 1983, Nature.

[7]  Luigi Mansi,et al.  The new FDG brain revolution: the neurovascular unit and the default network , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  L. Cardon,et al.  Replication of twelve association studies for Huntington’s disease residual age of onset in large Venezuelan kindreds , 2006, Journal of Medical Genetics.

[9]  Alan A. Wilson,et al.  Mu‐opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy , 1988, Annals of neurology.

[10]  Leslie G. Ungerleider,et al.  Dissociation of object and spatial visual processing pathways in human extrastriate cortex. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M E Raichle,et al.  Regional Correction of Positron Emission Tomography Data for the Effects of Cerebral Atrophy , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  M E Phelps,et al.  Interictal and postictal focal hypermetabolism on positron emission tomography. , 1993, Pediatric neurology.

[13]  M. Jüptner,et al.  Review: Does Measurement of Regional Cerebral Blood Flow Reflect Synaptic Activity?—Implications for PET and fMRI , 1995, NeuroImage.

[14]  J V Haxby,et al.  Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia. , 1997, The American journal of psychiatry.

[15]  D. Brooks,et al.  Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease , 1996, Annals of neurology.

[16]  L. Sokoloff,et al.  Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system. , 1981, Federation proceedings.

[17]  Jerry L Prince,et al.  Measurement of Radiotracer Concentration in Brain Gray Matter Using Positron Emission Tomography: MRI-Based Correction for Partial Volume Effects , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  J V Haxby,et al.  Pattern of cerebral metabolic interactions in a subject with isolated amnesia at risk for Alzheimer's disease: a longitudinal evaluation. , 1993, Dementia.

[19]  S. Rapoport,et al.  Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical review. , 1991, Cerebrovascular and brain metabolism reviews.

[20]  E. Godaux,et al.  Neuronal Deficiency of Presenilin 1 Inhibits Amyloid Plaque Formation and Corrects Hippocampal Long-Term Potentiation But Not a Cognitive Defect of Amyloid Precursor Protein [V717I] Transgenic Mice , 2002, The Journal of Neuroscience.

[21]  Gina N. LaRossa,et al.  [11C]PIB in a nondemented population , 2006, Neurology.

[22]  I. Feinberg,et al.  Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? , 1982, Journal of psychiatric research.

[23]  R. Brooks,et al.  The role of positron emission tomography in the evaluation of seizure disorders , 1984, Annals of neurology.

[24]  Arman Rahmim,et al.  Design and Implementation of an Automated Partial Volume Correction in PET: Application to Dopamine Receptor Quantification in the Normal Human Striatum , 2008, Journal of Nuclear Medicine.

[25]  Pietro Pietrini,et al.  Resting state brain glucose metabolism is not reduced in normotensive healthy men during aging, after correction for brain atrophy , 2004, Brain Research Bulletin.

[26]  J. Holzer,et al.  Brain Imaging—Applications in Psychiatry , 1991, The Yale Journal of Biology and Medicine.

[27]  Louis Sokoloff,et al.  Activity‐dependent Energy Metabolism in Rat Posterior Pituitary Primarily Reflects Sodium Pump Activity , 1980, Journal of neurochemistry.

[28]  G L Shulman,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .

[29]  S. DeKosky,et al.  Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  K. Wienhard,et al.  MRI-Guided Flumazenil- and FDG-PET in Temporal Lobe Epilepsy , 1996, NeuroImage.

[31]  M. Hayden,et al.  Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. , 2003, Brain : a journal of neurology.

[32]  J. Haxby,et al.  Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia , 1993, Neurobiology of Aging.

[33]  R N Gunn,et al.  Huntington's disease progression. PET and clinical observations. , 1999, Brain : a journal of neurology.

[34]  S. Stone-Elander,et al.  D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. , 1990, Archives of general psychiatry.

[35]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[36]  Stanley I. Rapoport,et al.  In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer’s disease , 1999, European Archives of Psychiatry and Clinical Neuroscience.

[37]  P. Seeman,et al.  Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. , 1975, Science.

[38]  M. Mintun,et al.  Nonoxidative glucose consumption during focal physiologic neural activity. , 1988, Science.

[39]  J V Haxby,et al.  High-resolution PET studies in Alzheimer's disease. , 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[40]  P. Herscovitch,et al.  Cerebral blood flow in temporal lobe epilepsy: a partial volume correction study , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[41]  A. Nordberg Amyloid plaque imaging in vivo: current achievement and future prospects , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[42]  J. Mazziotta,et al.  MRI‐PET Registration with Automated Algorithm , 1993, Journal of computer assisted tomography.

[43]  M. Laruelle Imaging dopamine transmission in schizophrenia. A review and meta-analysis. , 1998, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[44]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[45]  W. Gaillard,et al.  Neuroimaging and the progression of epilepsy. , 2002, Progress in brain research.

[46]  B. de Strooper,et al.  Presenilins: members of the gamma-secretase quartets, but part-time soloists too. , 2008, Physiology.

[47]  J. Hardy,et al.  Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer’s disease in vivo? , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[48]  N. Andreasen,et al.  Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients , 1997, The Lancet.

[49]  R. V. Van Heertum,et al.  Prefrontal Dopamine D1 Receptors and Working Memory in Schizophrenia , 2002, The Journal of Neuroscience.

[50]  A. Alavi,et al.  Ipsilateral and contralateral thalamic hypometabolism as a predictor of outcome after temporal lobectomy for seizures. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[51]  W. Leslie,et al.  Comparison of iodine-123-epidepride and iodine-123-IBZM for dopamine D2 receptor imaging. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[52]  W. H. Vance,et al.  Effects of antidromic stimulation of the ventral root on glucose utilization in the ventral horn of the spinal cord in the rat. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Hayden,et al.  The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. , 1997, American journal of human genetics.

[54]  Abraham Z. Snyder,et al.  A default mode of brain function: A brief history of an evolving idea , 2007, NeuroImage.

[55]  S. DeKosky,et al.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.

[56]  Richard E Carson,et al.  5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[57]  C. Meltzer,et al.  Planned Ictal FDG PET Imaging for Localization of Extratemporal Epileptic Foci , 2000, Epilepsia.

[58]  Igor Nenadic,et al.  Hypofrontality in unmedicated schizophrenia patients studied with PET during performance of a serial verbal learning task , 2000, Schizophrenia Research.

[59]  J. Frost Receptor imaging by PET and SPECT: focus on the opiate receptor. , 1993, Journal of receptor research.

[60]  A. Malhotra,et al.  Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[61]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[62]  Marc Laruelle,et al.  The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies , 2000, Brain Research Reviews.

[63]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[64]  Andrea Ciarmiello,et al.  Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[65]  Yvette I. Sheline,et al.  Potential antecedent marker of Alzheimer disease , 2006 .

[66]  W H Theodore,et al.  Interictal metabolism and blood flow are uncoupled in temporal lobe cortex of patients with complex partial epilepsy , 1995, Neurology.

[67]  Karl J. Friston,et al.  Hearing and saying. The functional neuro-anatomy of auditory word processing. , 1996, Brain : a journal of neurology.

[68]  R. V. Van Heertum,et al.  Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[69]  S. Petersen,et al.  Activation of extrastriate and frontal cortical areas by visual words and word-like stimuli. , 1990, Science.

[70]  A. Alavi,et al.  False Lateralization of Temporal Lobe Epilepsy with FDG Positron Emission Tomography , 1995, Epilepsia.

[71]  J C Mazziotta,et al.  Quantifying Interictal Metabolic Activity in Human Temporal Lobe Epilepsy , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[72]  W H Theodore,et al.  Hippocampal atrophy, epilepsy duration, and febrile seizures in patients with partial seizures , 1999, Neurology.

[73]  G. Bates,et al.  Huntingtin aggregation and toxicity in Huntington's disease , 2003, The Lancet.

[74]  W. Klunk,et al.  Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. , 2003, Journal of medicinal chemistry.

[75]  Patrick Kwan,et al.  Definition of refractory epilepsy: defining the indefinable? , 2010, The Lancet Neurology.

[76]  A. Crane,et al.  Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[77]  M. Hayden,et al.  The FDG/PET Methodology for Early Detection of Disease Onset: A Statistical Model , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[78]  N C Andreasen,et al.  Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[79]  A. Rominger,et al.  PET and SPECT in epilepsy: A critical review , 2009, Epilepsy & Behavior.

[80]  D. Eidelberg,et al.  Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[81]  W J Schwartz,et al.  Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat. , 1979, Science.

[82]  K. Jellinger,et al.  Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia. , 1990, European neurology.

[83]  G. Pearlson,et al.  Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. , 1986, Science.

[84]  A H Kaye,et al.  MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome. , 2004, Brain : a journal of neurology.

[85]  E. Masliah,et al.  Can Alzheimer disease be prevented by amyloid-β immunotherapy? , 2010, Nature Reviews Neurology.

[86]  S. Spencer The Relative Contributions of MRI, SPECT, and PET Imaging in Epilepsy , 1994, Epilepsia.

[87]  S. Weinstein,et al.  Prognosis of children with partial epilepsy , 2007, Neurology.

[88]  D. Ingvar,et al.  Absence of activation in frontal structures during psychological testing of chronic schizophrenics. , 1975, Journal of neurology, neurosurgery, and psychiatry.

[89]  D. V. van Essen,et al.  Retinotopic organization of human visual cortex mapped with positron- emission tomography , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[90]  Leslie G. Ungerleider,et al.  A neural system for human visual working memory. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[91]  G. Alexander,et al.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[92]  R Duncan,et al.  Ictal/postictal SPECT in the pre-surgical localisation of complex partial seizures. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[93]  D. Weinberger,et al.  CEREBELLAR ATROPHY IN CHRONIC SCHIZOPHRENIA , 1979, The Lancet.

[94]  E. Ringelstein,et al.  Temporal hypometabolism at the onset of cryptogenic temporal lobe epilepsy , 2001, European Journal of Nuclear Medicine.

[95]  C. Sherrington,et al.  On the Regulation of the Blood‐supply of the Brain , 1890, The Journal of physiology.

[96]  J. Krystal,et al.  Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[97]  G. Alexander,et al.  Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease , 1998, Neurology.

[98]  D J Brooks,et al.  Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI. , 2002, Brain : a journal of neurology.

[99]  M. D. de Leon,et al.  Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[100]  C. Jack,et al.  Subtraction ictal SPECT co‐registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus , 1998, Neurology.

[101]  P B Hoffer,et al.  Microdialysis and SPECT measurements of amphetamine‐induced dopamine release in nonhuman primates , 1997, Synapse.

[102]  Alberto Pupi,et al.  Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease , 2008, Annals of the New York Academy of Sciences.

[103]  M. Iyo,et al.  Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET , 1997, Nature.

[104]  J. Haxby,et al.  Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[105]  M. Buchsbaum,et al.  Hypofrontality in schizophrenia as assessed by PET. , 1987, The American journal of psychiatry.

[106]  J. Penney,et al.  Trinucleotide repeat length instability and age of onset in Huntington's disease , 1993, Nature Genetics.

[107]  D. Brooks,et al.  Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study. , 1995, Brain : a journal of neurology.

[108]  A. Ciarmiello,et al.  Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[109]  D E Kuhl,et al.  Positron emission tomography measures of benzodiazepine receptors in Huntington's disease , 1993, Annals of neurology.

[110]  J. Mazziotta,et al.  Presurgical evaluation for partial epilepsy , 1990, Neurology.

[111]  M. Mintun,et al.  Brain work and brain imaging. , 2006, Annual review of neuroscience.

[112]  J C Mazziotta,et al.  Tomographic mapping of human cerebral metabolism visual stimulation and deprivation. , 1981, Neurology.

[113]  M. Laruelle,et al.  Increased dopamine transmission in schizophrenia: relationship to illness phases , 1999, Biological Psychiatry.

[114]  P. T. Fox,et al.  Positron emission tomographic studies of the cortical anatomy of single-word processing , 1988, Nature.

[115]  M. Folstein,et al.  EFFECTS OF AGE ON DOPAMINE AND SEROTONIN RECEPTORS MEASURED BY POSITRON TOMOGRAPHY IN THE LIVING HUMAN BRAIN , 1984, Science.

[116]  E. Masliah,et al.  Can Alzheimer disease be prevented by amyloid-β immunotherapy? , 2010, Nature Reviews Neurology.

[117]  M E Raichle,et al.  Neuroanatomical circuits in depression: implications for treatment mechanisms. , 1992, Psychopharmacology bulletin.

[118]  James A. Scott,et al.  Positron Emission Tomography: Basic Science and Clinical Practice , 2004 .

[119]  H C Thode,et al.  Gamma distribution model describes maturational curves for delta wave amplitude, cortical metabolic rate and synaptic density. , 1990, Journal of theoretical biology.

[120]  D. Ingvar,et al.  Distribution of cerebral activity in chronic schizophrenia. , 1974, Lancet.

[121]  R. Heinrichs The primacy of cognition in schizophrenia. , 2005, The American psychologist.

[122]  W. van Paesschen,et al.  Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. , 1997, Brain : a journal of neurology.

[123]  Bryan L Roth,et al.  Molecular targets for treating cognitive dysfunction in schizophrenia. , 2007, Schizophrenia bulletin.

[124]  Pierre J. Magistretti,et al.  Cellular bases of functional brain imaging: insights from neuron-glia metabolic coupling 1 1 Published on the World Wide Web on 12 October 2000. , 2000, Brain Research.

[125]  B. Brinkmann,et al.  Subtraction peri-ictal SPECT is predictive of extratemporal epilepsy surgery outcome , 2000, Neurology.

[126]  Karl Herholz,et al.  Metabolic rates in small brain nuclei determined by high-resolution PET. , 2004, Journal of Nuclear Medicine.

[127]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[128]  I Savic,et al.  Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[129]  M. Torrens Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .

[130]  D J Brooks,et al.  Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission , 2000, Neurology.

[131]  C. Grady,et al.  Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease , 1987, Brain Research.

[132]  P Pietrini,et al.  Cerebral metabolic response to passive audiovisual stimulation in patients with Alzheimer's disease and healthy volunteers assessed by PET. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[133]  T. Shirao,et al.  Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.

[134]  W. Theodore,et al.  Complex Partial Seizures: Cerebellar Metabolism , 1987, Epilepsia.

[135]  D. Selkoe Aging, Amyloid, and Alzheimer's Disease: A Perspective in Honor of Carl Cotman , 2003, Neurochemical Research.